Skip to main content

Headlines

Cango Consensus Price Target Decreased by 35.83% to $19.64
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
New Era Energy & Digital Consensus Price Target Increased by 14.01% to $11.90
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Arbor Realty Trust Consensus Price Target Decreased by 16.67% to $5.10
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Phillips 66 Reaches Analyst Target Price
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Delek Logistics Partners Reaches Analyst Target Price
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Prediction: This Stock Could Double Over the Next 5 Years
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Should You Forget Tesla and Buy These 3 Robotics Stocks Instead?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Show Me The Money: Kodiak Sciences Shares Deliver More Than 500% Return In Just Over A Year
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
How to Earn $272 a Month From Realty Income (O) Stock (That's $3,264 Per Year)
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Hawaiian Electric Industries Consensus Price Target Lowered by 21.14% to $8.24
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Analog Chips Are the Silent Winners of the AI Trade. These 3 Growth Stocks Are Capitalizing on the Opportunity.
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Elmet Group Consensus Price Target Increased by 10.84% to $23.46
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
DAX Up Firmly As Oil Prices, Bond Yields Drop
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Iovance Biotherapeutics Consensus Price Target Increased by 34.74% to $13.06
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks